Global Intra-aortic balloon pump (IABP) industry is projected to reach USD 435.75 million USD by 2022 www.qyresearch.com
Contact
Beijing Hengzhou Bozhi International Information Consulting Web: qyresearchglobal.com | qyresearch.com
TEL:+86-13660489419, Office:+86-2022093278 Media: press@qyresearch.com Marketing: sales@qyresearchglobal.com www.qyresearch.com
Facebook: @QYResearchOfficial ,Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智
QYResearch • At present, in developed countries, the Intra-aortic Balloon Pump (IABP) industry is generally at a more advanced level. The world's largest enterprises are mainly concentrated in USA and Europe. Meanwhile, foreign companies have strong R & D capability, and leading technical level. The Intra-aortic balloon pump (IABP) industry was 314.85 million USD in 2016 and is projected to reach USD 435.75 million USD by 2022, at a CAGR (Compounded Annual Growth Rate) of 5.57% between 2016 and 2022. The Intra-aortic balloon pump (IABP) industry is high concentration and there are only two key brand: Maquet and Teleflex Incorporated. www.qyresearch.com
QYResearch • Intra-aortic balloon pump (IABP) is a cardiovascular medical device for temporarily improving cardiac function in human in life-threatening surgeries such as heart transplant, percutaneous coronary interventions and coronary artery bypass grafting. Intra-aortic balloon pump (IABP) is further used in cardiogenic shock and assisting left ventricular function. Intra-aortic balloon pump (IABP) consists two main components as, a double-lumen catheter with a distal end located inflatable bubble and a console that regulates the inflation and deflation of the balloon. Intra-aortic balloon pump (IABP) also improves the oxygen supply by increasing the blood flow to the coronary arteries and stabilize the patients with dysrhythmias and myocardial ischemia. The console manages the desired timing for balloon to inflate and deflate, which is filled by helium or carbon dioxide further helps in proper perfusion. The balloon inflates at the start of diastole and deflates before ventricular systole. www.qyresearch.com
QYResearch • Rising number of cardiovascular disorders are the main factors supporting the use of intra-aortic balloon pump. Though high procedure cost and inflammatory risks during the insertion of the balloon pump are some factors hindering the market growth. Surviving in highly competitive market and individual’s inaccessibility to the multispecialty cardiac care centers are the main challenges to overcome. Whereas Innovations in different sizes of the device pertaining to the height of the patient has improved the adoption rate for intra-aortic balloon pump. Life style changes and increasing obese population are the root cause for highly impaired cardiovascular system. According to Hoschman et al. approximately 7.5% of the patients of acute myocardial infarction have cardiogenic shock complication and have a mortality rate of 70% to 80%. www.qyresearch.com
QYResearch • North America contributes the maximum share in Intra-aortic balloon pump (IABP) market due to eating habits and other lifestyle changes. Eastern and Western Europe are expected to show a vital growth as the need for cure of heart ailments is on rise. With standard health care services in the country Japan with significant healthcare spending is expected to favour the market for intra-aortic balloon pump (IABP). Asia Pacific Intra-aortic balloon pump (IABP) Market is expected to gain traction for due to increase in healthcare expenditure. Amongst the Asian countries, China, ASEAN, Australia and New Zealand and South Korea is expected to be more promising because of having large population over 50 years. www.qyresearch.com
QYResearch • In the coming years, Intra-aortic Balloon Pump (IABP) market is expected to witness the highest growth rate in the Asia-Pacific region. Companies must be aware of their competitive surroundings within their market. Being aware of competitor’s strategy can prevent a lag in reaction to a change within this market. This especially true in the Intra-aortic Balloon Pump (IABP) Industry because of its high growth in the Asian Market. Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this area, the future will still have more new investment enter the field. Even so, the market is intensely competitive .
Click to view the full report: https://www.qyresearch.com/index/detail/561308/globalintra-aortic-balloon-pump-iabp-market www.qyresearch.com